Barrington Research Reiterates “Outperform” Rating for Paysign (NASDAQ:PAYS)

Paysign (NASDAQ:PAYS)‘s stock had its “outperform” rating reaffirmed by analysts at Barrington Research in a research note issued to investors on Wednesday,Benzinga reports. They presently have a $7.00 price target on the stock. Barrington Research’s price objective would indicate a potential upside of 225.58% from the company’s previous close.

Separately, Lake Street Capital started coverage on Paysign in a research report on Friday, December 20th. They set a “buy” rating and a $6.00 target price for the company.

Paysign Stock Down 5.3 %

PAYS opened at $2.15 on Wednesday. The business has a fifty day moving average of $2.64 and a 200 day moving average of $3.24. The stock has a market cap of $115.13 million, a P/E ratio of 14.33 and a beta of 0.93. Paysign has a 52-week low of $2.10 and a 52-week high of $5.59.

Paysign (NASDAQ:PAYS) last posted its quarterly earnings results on Tuesday, March 25th. The company reported $0.02 EPS for the quarter, hitting the consensus estimate of $0.02. The company had revenue of $15.61 million for the quarter, compared to the consensus estimate of $15.42 million. Paysign had a net margin of 14.28% and a return on equity of 30.64%. Equities analysts anticipate that Paysign will post 0.21 EPS for the current fiscal year.

Insider Buying and Selling

In related news, insider Topline Capital Management, Ll sold 120,000 shares of the business’s stock in a transaction that occurred on Tuesday, January 14th. The shares were sold at an average price of $3.24, for a total transaction of $388,800.00. Following the completion of the transaction, the insider now owns 5,336,146 shares in the company, valued at $17,289,113.04. The trade was a 2.20 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, CEO Mark Newcomer sold 61,000 shares of the stock in a transaction that occurred on Tuesday, January 21st. The shares were sold at an average price of $2.89, for a total transaction of $176,290.00. Following the sale, the chief executive officer now directly owns 9,075,886 shares of the company’s stock, valued at $26,229,310.54. The trade was a 0.67 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 695,900 shares of company stock valued at $2,106,810 over the last 90 days. Corporate insiders own 23.40% of the company’s stock.

Hedge Funds Weigh In On Paysign

A number of large investors have recently made changes to their positions in the business. Squarepoint Ops LLC boosted its position in shares of Paysign by 97.1% in the 4th quarter. Squarepoint Ops LLC now owns 148,847 shares of the company’s stock worth $450,000 after purchasing an additional 73,326 shares in the last quarter. Two Sigma Advisers LP raised its stake in Paysign by 901.7% in the fourth quarter. Two Sigma Advisers LP now owns 121,200 shares of the company’s stock valued at $366,000 after buying an additional 109,100 shares during the last quarter. Two Sigma Investments LP boosted its holdings in Paysign by 98.8% in the fourth quarter. Two Sigma Investments LP now owns 181,775 shares of the company’s stock worth $549,000 after acquiring an additional 90,346 shares in the last quarter. Occudo Quantitative Strategies LP grew its stake in shares of Paysign by 56.5% during the fourth quarter. Occudo Quantitative Strategies LP now owns 28,429 shares of the company’s stock worth $86,000 after acquiring an additional 10,268 shares during the last quarter. Finally, Millennium Management LLC increased its holdings in shares of Paysign by 123.6% during the fourth quarter. Millennium Management LLC now owns 325,334 shares of the company’s stock valued at $983,000 after acquiring an additional 179,814 shares in the last quarter. 25.89% of the stock is owned by institutional investors and hedge funds.

Paysign Company Profile

Paysign, Inc provides prepaid card programs, comprehensive patient affordability offerings, digital banking services, and integrated payment processing services for businesses, consumers, and government institutions. Its product offerings include solutions for corporate rewards, prepaid gift cards, general purpose reloadable debit cards, employee incentives, consumer rebates, donor compensation, clinical trials, healthcare reimbursement payments and pharmaceutical payment assistance, and demand deposit accounts accessible with a debit card.